Related Experiment Video
Updated: Jul 5, 2026
07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Huntington's disease. Part 1: essential background and management
Aimee Aubeeluck1, Eleanor Wilson
1School of Nursing, Queen's Medical Centre, University of Nottingham, UK.
British Journal of Nursing (Mark Allen Publishing)
|April 17, 2008
Summary
Huntington's disease is a progressive neurodegenerative disorder with complex motor, cognitive, and behavioral symptoms. Understanding its stages and multidisciplinary care is crucial for effective management and support.
Area of Science:
- Neurodegenerative Disorders
- Neurology
- Genetics
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by motor, cognitive, and behavioral impairments.
- The disease's gradual progression over years or decades presents significant challenges for healthcare and social support systems.
- The complexity and unpredictability of HD necessitate a comprehensive understanding for effective patient care.
Purpose of the Study:
- To provide essential background information for understanding and managing care for individuals with Huntington's disease.
- To discuss the main stages of HD, highlighting associated symptoms and challenges.
- To explore potential management and therapeutic strategies, including key treatment considerations.
Main Methods:
- Literature review and synthesis of current knowledge on Huntington's disease.
- Discussion of disease progression, symptomology across different stages.
- Analysis of management, therapeutic interventions, and multidisciplinary team roles.
Main Results:
- Identification of distinct stages in Huntington's disease progression, each with specific symptom profiles.
- Outline of challenges faced by patients and healthcare professionals.
- Exploration of various management and therapy options, emphasizing individualized treatment approaches.
Conclusions:
- Effective care for Huntington's disease requires a thorough understanding of its progressive nature and symptom complexity.
- A multidisciplinary team approach is vital for providing integrated health and social care.
- Ongoing professional support and tailored management strategies are essential as the disease advances.
More Related Videos
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...